The global hyperkalemia treatment market is witnessing significant growth, driven by an increasing prevalence of chronic diseases such as diabetes and kidney failure. This conditions can lead to abnormally increased potassium levels in the blood, known as hyperkalemia. The market is further fueled by factors like an aging population, rising healthc